ER WILDTYPE

Clinical trials for ER WILDTYPE explained in plain language.

Never miss a new study

Get alerted when new ER WILDTYPE trials appear

Sign up with your email to follow new studies for ER WILDTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat breast cancer: two drugs vs. one

Disease control Recruiting now

This study is testing if combining two drugs, capecitabine and elacestrant, works better than just capecitabine alone for people with advanced, hormone-sensitive breast cancer. It's for patients whose cancer has stopped responding to a common class of prior medications. The main …

Matched conditions: ER WILDTYPE

Phase: PHASE2 • Sponsor: Kristina A. Fanucci • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

ER WILDTYPE

Get alerted when new ER WILDTYPE trials appear

New hope for Tough-to-Treat breast cancer: two drugs vs. one